Roles of C-reactive protein and LOX-1 on cancer and myeloid-derived suppressor cells in the progression of uterine cervical cancer
- Michihide Maeda 1,2,3, Seiji Mabuchi 4,5,6, Takashi Akazawa 3, Yu Mizote 3, Tomoyuki Sasano 7, Naoko Komura 8, Mina Sakata 1,2, Tsuyoshi Takiuchi 1, Shinya Matsuzaki 1,2, Tsuyoshi Hisa 2, Harumi Nakamura 9, Tomoya Ekawa 3, Shoji Kamiura 2, Tadashi Kimura 1, Hideaki Tahara 3,10
- Michihide Maeda 1,2,3, Seiji Mabuchi 4,5,6, Takashi Akazawa 3
- 1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
- 2Department of Gynecology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan.
- 3Department of Cancer Drug Discovery and Development, Research Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan.
- 4Department of Gynecology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan. seijimabuchi@hyo-med.ac.jp.
- 5Department of Cancer Drug Discovery and Development, Research Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan. seijimabuchi@hyo-med.ac.jp.
- 6Department of Obstetrics and Gynecology, Hyogo Medical University, 1-1 Mukogawacho, Nishinomiya, Hyogo, 663-8131, Japan. seijimabuchi@hyo-med.ac.jp.
- 7Department of Obstetrics and Gynecology, Osaka Saiseikai Nakatsu Hospital, 2-10-39 Shibata, Kita-ku, Osaka, 530-0012, Japan.
- 8Department of Obstetrics and Gynecology, Kaizuka City Hospital, 3-10-20 Hori, Kaizuka, Osaka, 597-0015, Japan.
- 9Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan.
- 10Center for Clinical Research, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-0008, Japan.
- 0Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Elevated C-reactive protein (CRP) levels worsen outcomes in cervical cancer patients with LOX-1 expressing tumors, indicating CRP and LOX-1 as potential therapeutic targets.
Area Of Science
- Oncology
- Immunology
- Biochemistry
Background
- C-reactive protein (CRP) is an inflammatory marker.
- The receptor LOX-1 (lectin-like oxidized LDL receptor 1) role in cancer is emerging.
- Understanding CRP and LOX-1 interplay in cervical cancer is crucial for treatment.
Purpose Of The Study
- To investigate the clinical significance of CRP and LOX-1 in cervical cancer progression.
- To elucidate the mechanisms by which CRP promotes cervical cancer via LOX-1.
Main Methods
- Analysis of clinical data from 121 cervical cancer patients treated with radiotherapy.
- In vitro studies using cervical cancer cell lines.
- In vivo studies using mouse xenograft models.
- Assessment of CRP levels, LOX-1 expression, and patient survival.
Main Results
- Elevated pretreatment CRP levels correlated with shorter overall survival in patients with LOX-1-expressing tumors.
- CRP promoted proliferation and progression of LOX-1-expressing cervical cancer cells in vitro and in vivo.
- CRP enhanced myeloid-derived suppressor cell (MDSC) survival and suppressive function.
- CRP's tumor-promoting effects were minimal in tumors lacking LOX-1 expression.
Conclusions
- CRP facilitates the progression of LOX-1-expressing cervical cancer by activating LOX-1 signaling in cancer cells and MDSCs.
- Targeting CRP or LOX-1 presents a potential therapeutic strategy for LOX-1-expressing cervical cancers.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:22
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

